Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ · Healthcare
Kiniksa Pharmaceuticals International, plc Net Income 2021–2025
Kiniksa Pharmaceuticals International, plc annual/quarterly net income history and growth rate from 2021 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Kiniksa Pharmaceuticals International, plc net income for the quarter ending March 31, 2026 was 22.6 M, a 164.57% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc net income for the twelve months ending March 31, 2026 was 67.4 M, a 239.95% decrease year-over-year.
- Kiniksa Pharmaceuticals International, plc annual net income for 2025 was 59.0 M, a 236.61% decrease from 2024.
- Kiniksa Pharmaceuticals International, plc annual net income for 2024 was -43.2 M, a 406.68% decrease from 2023.
- Kiniksa Pharmaceuticals International, plc annual net income for 2023 was 14.1 M, a 92.32% decrease from 2022.
- Kiniksa Pharmaceuticals International, plc annual net income for 2022 was 183.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Kiniksa Pharmaceuticals International, plc Net Income — FAQ
Kiniksa Pharmaceuticals International, plc (KNSA) net income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Kiniksa Pharmaceuticals International, plc's net income?
Kiniksa Pharmaceuticals International, plc (KNSA) reported net income of $59M for fiscal 2025.
Where can I see KNSA's net income history?
The chart and table above show Kiniksa Pharmaceuticals International, plc's net income by year and by quarter, including the growth rate.